miR-34a plays an important role in lymph node metastases of TSCC through targeting MMP9 and MMP14 and may have potential applications in prognosis prediction and gene therapy for lymph node metastases of TSCC patients. Here, MMP14 is linked to metastatic malignant neoplasm in the lymph nodes.